	Comment on "Theranostic lipid nanocarriers for precision diagnosis and targeted therapy in pancreatic ductal adenocarcinoma". J Cancer Res Clin Oncol Khakimovna KA, Bakhodirjon S, Armstrong JJ. PMID: 42789102 [PubMed - indexed for MEDLINE]
	Endoscopic ultrasound-guided fiducial marker placement for image-guided proton beam therapy in pancreatic cancer: implications for positional accuracy and position management. J Radiat Res Takeuchi K, Ishikawa T, Yamao K, Mizutani Y, Iida T, Takada Y, Tomida M, Yanagi T, Shibamoto Y, Toyama T, Yamao K, Narita M, Ashida R, Yamamura T, Kawashima H. PMID: 42786604 [PubMed - as supplied by publisher]
	Metastatic pancreatic cancer: from human disease to preclinical modelling. Gut Min J, Liaki V, Yu PY, Guerra C, Maitra A. PMID: 42785979 [PubMed - as supplied by publisher]
	When immunotherapy mimics pancreatic cancer: mass-forming immune-related pancreatitis during neoadjuvant treatment for triple-negative breast cancer. BMJ Case Rep Mouchet M, Gourmaud J, Kamel ME, Courtès MG. PMID: 42785764 [PubMed - indexed for MEDLINE]
	Glucose-containing carriers in cancer therapy (GLUCOSE-ONC): A multistream critical review and quantitative exposure framework. Neoplasia Kashiwagi S, Watanabe C, Asaka Y, Henmi S, Matsuda H, Ding H, Kikukawa Y, Gose A, Nishimoto M, Kochi A, Takada K, Tauchi Y, Ogisawa K, Shibutani M, Fujita H, Morisaki T, Kinoshita H. PMID: 42785157 [PubMed - as supplied by publisher]
	GPAT3 protects against lipid stress-induced ferroptosis in hepatocellular carcinoma: From multi-omics analysis to functional validation. Biochim Biophys Acta Mol Basis Dis Zhao Y, Yang J, Zhu W, Zhang G, Rui S, Ma T, Guo Z, Zhou W. PMID: 42785105 [PubMed - as supplied by publisher]
	Glucagon-like Peptide-1 Receptor Agonists Are Not Associated with Increased Risk of Acute Pancreatitis or Pancreatic Complications, Including Pancreatic Cancer, in Type 2 Diabetes: A Global Propensity-Matched Cohort Study. J Pers Med Sun Y, Liu B, Loh H, Mathialagan S, Lin CH, Tarabichi Y, Veccia D, Wong R, Tse W, Song G. PMID: 42783509 [PubMed]
	Suicide Risk and Associated Factors in Patients with Pancreatic Cancer: A Systematic Review. Diseases Chicoisneau M, Bouchart C, Hein M. PMID: 42783239 [PubMed]
	FGFR2 Fusions in Pancreatobiliary and Ampullary Cancers: High Detection Rate in FFPE Specimens of Intrahepatic Cholangiocarcinoma with Limited RNA Yields Using Amplicon-Based NGS Assay. Curr Oncol Guertin S, Sina N, Kron K, Craddock KJ, McCarty A, Hwang DM, Huang WY. PMID: 42782905 [PubMed - indexed for MEDLINE]
	Practical Considerations in the Radiotherapy Treatment Planning for SBRT Pancreas Program. Curr Oncol Joseph K, Burke B, Heikal A, Yip E, Murland S, Wong C, Kunheri B. PMID: 42782866 [PubMed - indexed for MEDLINE]
	Biomarker-Driven Strategies for Stromal Reprogramming in Pancreatic Ductal Adenocarcinoma. Cells De Luca M, Balestra F, Panzetta G, Giannelli G, Scavo MP. PMID: 42782738 [PubMed - indexed for MEDLINE]
	Prognostic Value of the C-Reactive Protein-Albumin-Lymphocyte Index in Hepatobiliary and Pancreatic Cancers: A Systematic Review and Meta-Analysis. J Gastrointest Cancer Shamohammadi M, Arianezhad E, Yarahmadi D, Ullah SE, Teymoori MH, Shams Z, Nikkhah A, Tizmaghz A, Zarghami SY. PMID: 42782412 [PubMed - indexed for MEDLINE]
	Machine learning models for predicting liver cancer: a real-world cohort study in China. Front Cell Dev Biol Fu C, Li F, Li S, Lin R, Yuan Z. PMID: 42780702 [PubMed]
	Association Between Malnutrition and Therapy Intolerance in Cancer Patients: An Observational Cohort Study. J Acad Nutr Diet Negri Jimenez AL, Werts-Pelters SJ, Schmitz KH. PMID: 42777809 [PubMed - as supplied by publisher]
	Single-cell landscape reveals PLPP2 upregulation underlying radiotherapy resistance and immune microenvironment remodeling in pancreatic cancer. Transl Oncol Wang Y, Kaysar P, Ma Y, Liu Z, Han Y, Liu W, Pang H, Zhou Y. PMID: 42777648 [PubMed - as supplied by publisher]
	Extracellular vesicle-mediated drug resistance in cancer. Drug Resist Updat Zhao B, Chen Y, Khan H, Wang Y, Tang H, Swati K, Anand K, Parvez S, Lin Y, Wu H. PMID: 42777406 [PubMed - as supplied by publisher]
	Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer. J Clin Oncol Ikeda M, Nakachi K, Konishi M, Kajikawa R, Katayama H, Sano Y, Sugiura T, Satoi S, Murakawa M, Tomokuni A, Nara S, Takahashi Y, Okada KI, Hama N, Kamei K, Kamata K, Natsume S, Okusaka T, Furuse J, Ueno M. PMID: 42777180 [PubMed - as supplied by publisher]
	Clinical and Proteomic Biomarkers of Trifluridine/Tipiracil in Fluoropyrimidine-Refractory Advanced Pancreatic Adenocarcinoma: A Single-Arm Phase II Trial. JCO Precis Oncol Chiang CL, Chan SKK, Lee ASF, Lam KME, Wong CYE, Chan CWD, Chan KSK, Li S, Wong WHJ, Chiu WHK, Lo CLR. PMID: 42777178 [PubMed - indexed for MEDLINE]
	Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer. JAMA Netw Open Dall'Olio T, Capurso G, Terrin M, De Luca R, Coluccio C, Arcangeli V, Milanetto AC, Butturini G, Fantin A, Barresi L, De Marchi G, Galli A, Di Marco M, Panzuto F, Sassatelli R, Ricci C, Di Matteo FM, Spinelli E, Dal Buono A, Patruno M, Cavestro GM, Venturini E, Arcidiacono PG, Salvia R, Falconi M, Carrara S, Archibugi L, Paiella S, Italian Registry of Families at Risk of Pancreatic Cancer Study Group. PMID: 42776526 [PubMed - indexed for MEDLINE]
	A guide to transcriptional cyclin-dependent kinases in cancer. FEBS J Devlin JR, Kyheröinen S, Johnstone RW. PMID: 42775925 [PubMed - as supplied by publisher]

Articles 1 - 20 / 61632

Page 1 of 3082



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy